Catalyst
Slingshot members are tracking this event:
OPKO (OPK) Announces U.S. Launch of RAYALDEE
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
OPK |
|
|
Additional Information
The U.S. launch of RAYALDEE follows the successful introduction of the product to thousands of nephrologists attending the American Society of Nephrology (ASN) Kidney Week Meeting last week in Chicago. RAYALDEE was approved by the U.S. Food and Drug Administration (FDA) on June 17, 2016.
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 23, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rayaldee, U.s Commercial Launch